Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma

Although RNA interference (RNAi) therapy has emerged as a potential tool in cancer therapeutics, the application of RNAi to glioblastoma (GBM) remains a hurdle. Herein, to improve the therapeutic effect of RNAi on GBM, a cancer cell membrane (CCM)-disguised hypoxia-triggered RNAi nanomedicine was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhen, Tang, Xiang-long, Zhao, Meng-jie, Zhang, Yi-ding, Xiao, Yong, Liu, Yu-yang, Qian, Chun-fa, Xie, Yan-dong, Liu, Yong, Zou, Yuan-jie, Yang, Kun, Liu, Hong-yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324258/
https://www.ncbi.nlm.nih.gov/pubmed/37408007
http://dx.doi.org/10.1186/s12951-023-01960-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324258/
https://www.ncbi.nlm.nih.gov/pubmed/37408007
http://dx.doi.org/10.1186/s12951-023-01960-w

Ejemplares similares